AtlanChim Pharma

Executive Summary

AtlanChim Pharma is a French chemical synthesis laboratory based in Nantes, founded in 2013. The company offers custom synthesis services to pharmaceutical, biotechnology, cosmetics, food, and academic sectors, specializing in complex organic molecules such as heterocycles, chiral molecules, steroids, alkaloids, and stable isotope-labeled compounds. As a private contract research organization (CRO), AtlanChim Pharma supports research and development by synthesizing compounds not described in literature and incorporating stable isotopes via cold labeling. With a focus on small molecules and oncology applications, the firm positions itself as a versatile partner for early-stage drug discovery and chemical development. Despite limited public information on funding, stage, or revenue, the company's broad service portfolio and established presence in the European CRO market suggest stable operations. However, the lack of disclosed financials or pipeline projects prevents deep assessment of growth trajectory. Overall, AtlanChim Pharma appears well-suited for niche custom synthesis needs but may face competition from larger CROs.

Upcoming Catalysts (preview)

• TBDExpansion into new therapeutic areas or geographic markets40% success
• TBDAnnouncement of strategic partnership with a major pharma or biotech30% success
• TBDIntroduction of new synthesis technology or service line (e.g., peptide or oligonucleotide synthesis)50% success